Noura Abbas

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Ali I. Shamseddine · 3 shared papers, 2024–2026 · strength 0.95
   • Paper Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma: from Tumor Biology to Biomarker-Guided Strategies. DOI 10.1007/s11912-026-01812-4↗
   • Paper An Atypical Case of Pancreatic Cancer with Mesenchymal Differentiation in a Patient with Primary Lung Adenocarcinoma: I… DOI 10.3390/diagnostics14222512↗
   • Paper Clinicopathological and Prognostic Implications of Epithelial-to-Mesenchymal Transition-Related Immunohistochemical Mar… DOI 10.1002/cnr2.70565↗
2. Layal Al Mahmasani · 1 shared paper, 2026 · strength 0.43
   • Paper Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma: from Tumor Biology to Biomarker-Guided Strategies. DOI 10.1007/s11912-026-01812-4↗
3. Walid Ghazi Faraj · 1 shared paper, 2026 · strength 0.24
   • Paper Clinicopathological and Prognostic Implications of Epithelial-to-Mesenchymal Transition-Related Immunohistochemical Mar… DOI 10.1002/cnr2.70565↗
4. Ahmad Machmouchi · 1 shared paper, 2026 · strength 0.24
   • Paper Clinicopathological and Prognostic Implications of Epithelial-to-Mesenchymal Transition-Related Immunohistochemical Mar… DOI 10.1002/cnr2.70565↗
5. Laudy Chehade · 1 shared paper, 2026 · strength 0.24
   • Paper Clinicopathological and Prognostic Implications of Epithelial-to-Mesenchymal Transition-Related Immunohistochemical Mar… DOI 10.1002/cnr2.70565↗
6. Sally Naji Temraz · 1 shared paper, 2026 · strength 0.24
   • Paper Clinicopathological and Prognostic Implications of Epithelial-to-Mesenchymal Transition-Related Immunohistochemical Mar… DOI 10.1002/cnr2.70565↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.